HomeDXCM • NASDAQ
add
DexCom Inc
Previous close
$88.37
Day range
$85.64 - $88.74
Year range
$62.34 - $142.00
Market cap
33.59B USD
Avg Volume
3.64M
P/E ratio
61.59
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.11B | 7.64% |
Operating expense | 466.90M | 6.19% |
Net income | 151.70M | -40.81% |
Net profit margin | 13.62 | -45.04% |
Earnings per share | 0.45 | -10.00% |
EBITDA | 246.70M | -8.43% |
Effective tax rate | 28.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.58B | -5.31% |
Total assets | 6.48B | 3.51% |
Total liabilities | 4.38B | 4.43% |
Total equity | 2.10B | — |
Shares outstanding | 390.77M | — |
Price to book | 16.43 | — |
Return on assets | 7.36% | — |
Return on capital | 10.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 151.70M | -40.81% |
Cash from operations | 301.40M | 125.60% |
Cash from investing | -303.70M | -173.20% |
Cash from financing | -1.60M | 99.75% |
Net change in cash | -15.10M | 80.47% |
Free cash flow | 143.20M | 354.35% |
About
DexCom, Inc. is an American heathcare company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250
